Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic.

ABSTRACT:

Importance

Little is known about the potential implications of the rapid transition to telehealth during the COVID-19 pandemic for treatment of opioid use disorder (OUD).

Objective

To examine the association between telemedicine adoption during the COVID-19 pandemic and indicators of OUD treatment quality.

Design, setting, and participants

This cohort study analyzed deidentified administrative claims data from OptumLabs Data Warehouse. Claims for telemedicine visits were included for both the prepandemic period (March 14, 2019, to March 13, 2020) and pandemic period (March 14, 2020, to March 13, 2021). Patients with OUD and continuous enrollment in either commercial insurance or Medicare Advantage plans were included. Clinicians who provided office-based OUD care were

SUBMITTER: Hailu R 

PROVIDER: S-EPMC10038015 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature